SCHEMBL13508461

SCHEMBL13508461

C(=C1c2ccccc2COCc2ccccc21)c1ccc(N(c2ccc(C=C3c4ccccc4COCc4ccccc43)cc2)c2ccc(C=C3c4ccccc4COCc4ccccc43)cc2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 3/20 0.39
MAOA P21397 2/20 0.38
MIF P14174 1/20 0.38
NR3C2 P08235 3/20 0.37
CYP19A1 P11511 1/20 0.36
CYP11B2 P19099 1/20 0.36
MEN1 O00255 6/20 0.35
KMT2A Q03164 6/20 0.35
ALDH1A1 P00352 5/20 0.35
MAPT P10636 5/20 0.35
APP P05067 3/20 0.35
SNCA P37840 3/20 0.35
PDGFRB P09619 2/20 0.35
MAPK1 P28482 2/20 0.35
TDP1 Q9NUW8 2/20 0.35
LMNA P02545 2/20 0.35
CYP1A2 P05177 2/20 0.35
CYP2D6 P10635 2/20 0.35
TSHR P16473 2/20 0.35
HPGD P15428 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13508378 0.86 HTR2B (0.50) MAOBMIFNR3C2MEN1KMT2A
SCHEMBL13508434 0.85 CYP19A1 (0.44) MAOBMAOAMIFNR3C2CYP19A1
SCHEMBL13508410 0.85 MAOB (0.48) MAOBMAOAMIFCYP19A1CYP11B2
SCHEMBL13508401 0.79 CYP19A1 (0.55) MIFCYP19A1CYP11B2MEN1KMT2A
SCHEMBL12998636 0.78 MIF (0.55) MAOBMAOAMIFNR3C2CYP19A1
SCHEMBL14570730 0.75 CYP19A1 (0.52) MIFCYP19A1CYP11B2MEN1KMT2A
SCHEMBL13508455 0.75 MIF (0.54) MAOBMAOAMIFCYP19A1CYP11B2
SCHEMBL13508398 0.74 MAOB (0.42) MAOBMAOAMIFCYP19A1CYP11B2
SCHEMBL13508381 0.73 HTR6 (0.46) MIFCYP19A1CYP11B2MEN1KMT2A
SCHEMBL4165013 0.72 MAOB (0.56) MAOBMAOAMIFMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1761962-B1 ORGANIC ELECTROLUMINESCENT DEVICE MERCK PATENT GMBH (DE) 2010-02-03 EP disclosed
US-20090159874-A1 Organic electroluminescent devices MERCK PATENT GMBH (DE) 2009-06-25 US disclosed
US-20090159874-A1 Organic electroluminescent devices MERCK PATENT GMBH (DE) 2009-06-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090159874-A1 Organic electroluminescent devices LEF1, NCS1, CRY1 MAOB 504/4885MAOA 613/4885MIF 2402/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.